MHRA homes in on personalised healthcare and tech in new 2030 strategy
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has devised a new strategy to better harness advancements in personalised…
News
IgniteData, RealTime join forces to automate clinical trial data transfers
Dosing completed in Calluna Pharma’s Phase II AURORA trial
BioNTech misses PFS endpoints in Phase II/III cancer vaccine trial
Regeneron reports 84-week Phase III data for Pasatru in adult FOP
Tortugas’ Phase IIb schizophrenia trial of obuprazine meets primary endpoint
BMS gains two pivotal trial wins in lung disease and rare cancer
Mirum tees up Livmarli label expansion on Phase III liver disease study success
